Microbes and colorectal cancer: Is there a relationship?

Current Oncology

Volumn 16, Issue 4, 2009, Pages 22-24

  Uronis, J M ^a   Jobin, Christian ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Colitis; Colorectal cancer; Inflammatory bowel disease; Nod like receptor; Toll like receptor

Indexed keywords

APC PROTEIN; BETA CATENIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; WNT PROTEIN;

ADAPTIVE IMMUNITY; BACTERIAL IMMUNITY; CANCER RISK; COLON CARCINOGENESIS; COLON FLORA; COLON POLYPOSIS; COLORECTAL CANCER; CROHN DISEASE; GENE DELETION; GENE MUTATION; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 70350576477     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-13785 (Pubitemid 350003397)
2. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65-80.
3. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449:804-810
4. Mullard A. Microbiology: the inside story. Nature 2008;453:578-580
5. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533 (Pubitemid 37328672)
6. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17. (Pubitemid 38802113)
7. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-459 (Pubitemid 38182302)
8. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol 2008;14:378-389
9. Min mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 1997;57:812-814
10. Beutler BA. TLRS and innate immunity. Blood 2009;113:1399-1407
11. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007;317:124-127 (Pubitemid 47056471)
12. Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2007;2:1998-2004. (Pubitemid 47308138)
13. Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007;133:1869-1881 (Pubitemid 350186162)
14. Chen GY, Shaw MH, Redondo G, Nunez G. The innate immune receptor NOD1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res 2008;68:10060-10067
15. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009;15:103-113
16. Karrasch T, Jobin C. NF-κB and the intestine: friend or foe? Inflamm Bowel Dis 2008;14:114-124
17. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241 (Pubitemid 38962578)
18. Rakoff-Nahoum S, Hao L, Medzhitov R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006;25:319-329 (Pubitemid 44224143)
19. Uronis JM, Muehlbauer M, Herfarth HH, Jones GS, Rubinas TC, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 2009;4:e6026.